Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer.

Cancer Discovery
Chengheng LiaoQing Zhang

Abstract

Triple-negative breast cancer (TNBC) is an aggressive and highly lethal disease. Because of its heterogeneity and lack of hormone receptors or HER2 expression, targeted therapy is limited. Here, by performing a functional siRNA screening for 2-OG-dependent enzymes, we identified gamma-butyrobetaine hydroxylase 1 (BBOX1) as an essential gene for TNBC tumorigenesis. BBOX1 depletion inhibits TNBC cell growth while not affecting normal breast cells. Mechanistically, BBOX1 binds with the calcium channel inositol-1,4,5-trisphosphate receptor type 3 (IP3R3) in an enzymatic-dependent manner and prevents its ubiquitination and proteasomal degradation. BBOX1 depletion suppresses IP3R3-mediated endoplasmic reticulum calcium release, therefore impairing calcium-dependent energy-generating processes including mitochondrial respiration and mTORC1-mediated glycolysis, which leads to apoptosis and impaired cell-cycle progression in TNBC cells. Therapeutically, genetic depletion or pharmacologic inhibition of BBOX1 inhibits TNBC tumor growth in vitro and in vivo. Our study highlights the importance of targeting the previously uncharacterized BBOX1-IP3R3-calcium oncogenic signaling axis in TNBC. SIGNIFICANCE: We provide evidence from unbiased sc...Continue Reading

References

Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·O ThastrupA P Dawson
Oct 1, 1983·Physiological Reviews·J Bremer
Oct 1, 1998·Biochemical and Biophysical Research Communications·F M VazR J Wanders
Apr 13, 2007·Physiological Reviews·J Kevin FoskettDon-On Daniel Mak
Dec 18, 2007·Cell·David E Clapham
Apr 25, 2008·Nature Reviews. Cancer·H Llewelyn Roderick, Simon J Cook
May 8, 2008·Cell Metabolism·Pawan GulatiGeorge Thomas
May 24, 2008·Molecular Cell·William G Kaelin, Peter J Ratcliffe
Apr 4, 2009·Biochimica Et Biophysica Acta·Rosario RizzutoPaolo Pinton
Jul 15, 2009·Clinical Breast Cancer·Carey K Anders, Lisa A Carey
Sep 4, 2010·Breast Cancer Research : BCR·Aleix PratCharles M Perou
Nov 16, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Sunil BadveJorge S Reis-Filho
Dec 21, 2010·Chemistry & Biology·Ivanhoe K H LeungChristopher J Schofield
Oct 4, 2011·Cell·Michael J EmanueleStephen J Elledge
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Otto Metzger-FilhoMartine Piccart-Gebhart
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
May 25, 2012·Breast Cancer Research : BCR·Yi Fang LeeKartiki V Desai
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Nov 7, 2012·Molecular and Cellular Biology·Fatih MercanAnton M Bennett
May 1, 2013·Genes & Development·Julie-Aurore Losman, William G Kaelin
Sep 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Abdallah MoundFabrice Matifat
Feb 28, 2014·Journal of Medicinal Chemistry·Kaspars TarsOsvalds Pugovics
Jul 16, 2015·Cancer Biology & Medicine·Hanan Ahmed Wahba, Hend Ahmed El-Hadaad
Jan 23, 2016·Molecular Aspects of Medicine·Mun Chiang ChanPeter J Ratcliffe
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Jun 6, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Edgars Liepinsh, Maija Dambrova
Oct 28, 2016·ELife·Ruo-Jing LiJun O Liu
Jan 26, 2017·Acta Pharmaceutica Sinica. B·Chaochu CuiZui Pan
Apr 8, 2017·Nature Reviews. Cancer·Gregory R MonteithSarah J Roberts-Thomson
Apr 16, 2017·Current Opinion in Cell Biology·Issam Ben-Sahra, Brendan D Manning

❮ Previous
Next ❯

Citations

Nov 5, 2020·International Journal of Molecular Sciences·Guang YangQing Zhang
Nov 27, 2020·Molecular & Cellular Oncology·Chengheng Liao, Qing Zhang
Sep 22, 2021·Molecular Cell·Chaoyun PanM Celeste Simon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis